Dunlap Ryan has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 574385 shares of CytoDyn Inc. ($CYDY) on March 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | CytoDyn Inc. | $CYDY | Dunlap Ryan | Director | A | Non-qualified stock option (right to buy) | 574385 | $0.00 | 574,385.0000 | 1,261,016,000 | 9999.99% | 0.05% |
| Oct. 28, 2024 | CytoDyn Inc. | $CYDY | Dunlap Ryan | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 1,198,287,000 | 9999.99% | 0.07% |
| Jan. 3, 2024 | CytoDyn Inc. | $CYDY | Dunlap Ryan | Director | A | Non-qualified stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 958,988,000 | 9999.99% | 0.08% |